C07C 215/22
The carbon skeleton being unsaturated
Official title: the carbon skeleton being unsaturated
C07C215/22 (The carbon skeleton being unsaturated) appears on 391 US grants and 314 published applications in this corpus.
Search patents in C07C- Granted patents
- 391
- Published applications
- 314
- Assignees
- 224
- Inventors
- 964
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 6 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 12 | 0 |
| 1993 | 10 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 33 | 0 |
| 1997 | 34 | 0 |
| 1998 | 18 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 11 | 3 |
| 2002 | 8 | 13 |
| 2003 | 12 | 19 |
| 2004 | 7 | 15 |
| 2005 | 7 | 16 |
| 2006 | 6 | 14 |
| 2007 | 10 | 12 |
| 2008 | 12 | 17 |
| 2009 | 9 | 17 |
| 2010 | 7 | 12 |
| 2011 | 5 | 14 |
| 2012 | 10 | 13 |
| 2013 | 13 | 14 |
| 2014 | 14 | 19 |
| 2015 | 10 | 14 |
| 2016 | 11 | 12 |
| 2017 | 4 | 7 |
| 2018 | 5 | 13 |
| 2019 | 10 | 10 |
| 2020 | 13 | 13 |
| 2021 | 7 | 11 |
| 2022 | 4 | 7 |
| 2023 | 7 | 12 |
| 2024 | 5 | 10 |
| 2025 | 10 | 3 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for the preparation of (9S)-2-bromo-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[1,5-A]azepine6 Oct 2026US 12,753,175 B2Hoffmann-La Roche Inc.
- Ionizable lipid compounds and lipid nanoparticle compositions16 Jun 2026US 12,655,114 B2SunVax mRNA Therapeutics Inc.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Lipid compound and use thereof in delivery of nucleic acid30 Dec 2025US 12,508,225 B2Beijing Tricisionbio Therapeutics Inc.
- Chiral multidentate ligand, and application thereof in asymmetric hydrogenation16 Dec 2025US 12,497,424 B2Shenzhen Catalys Technology Co., Ltd
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Cationic lipids and uses thereof19 Mar 2026US 2026/0078081 A1Factor Bioscience Inc.
- Cationic lipids and transfection methods5 Feb 2026US 2026/0035336 A1Factor Bioscience Inc.
- Application of compound or traditional chinese medicine extract in preparation of nucleic acid delivery agent, and related products1 Jan 2026US 2026/0000768 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Process for preparing beta 3 agonists and intermediates2 Oct 2025US 2025/0304588 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Modulators of ATP-binding cassette transporters97US 8,324,242 B2Vertex Pharmaceutical Incorporated · 2012